• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Editorial: choosing the optimal screening method for latent TB in patients with IBD commencing anti-TNF-therapy-authors' reply.

作者信息

Kumar Peeyush, Vuyyuru Sudheer Kumar, Kedia Saurabh, Ahuja Vineet

机构信息

Department of Gastroenterology and Human Nutrition, All India Institute of Medical Sciences, New Delhi, India.

出版信息

Aliment Pharmacol Ther. 2022 May;55(10):1348-1349. doi: 10.1111/apt.16918.

DOI:10.1111/apt.16918
PMID:35472186
Abstract
摘要

相似文献

1
Editorial: choosing the optimal screening method for latent TB in patients with IBD commencing anti-TNF-therapy-authors' reply.社论：为开始抗TNF治疗的炎症性肠病患者选择最佳潜伏性结核筛查方法——作者回复
Aliment Pharmacol Ther. 2022 May;55(10):1348-1349. doi: 10.1111/apt.16918.
2
Editorial: choosing the optimal screening method for latent TB in patients with IBD commencing anti-TNF therapy.社论：为开始抗TNF治疗的炎症性肠病患者选择最佳的潜伏性结核筛查方法。
Aliment Pharmacol Ther. 2022 May;55(10):1346-1347. doi: 10.1111/apt.16878.
3
Inflammatory bowel disease and mycobacteria: how much can we trust isoniazid prophylaxis during antitumor necrosis factor therapy?炎症性肠病与分枝杆菌：在使用抗肿瘤坏死因子治疗期间，我们对异烟肼预防能有多大程度的信任？
Eur J Gastroenterol Hepatol. 2019 Jul;31(7):777-780. doi: 10.1097/MEG.0000000000001403.
4
Risk of tuberculosis in patients treated with anti-tumor necrosis factor therapy: a nationwide study in South Korea, a country with an intermediate tuberculosis burden.接受抗肿瘤坏死因子治疗的患者患结核病的风险：在韩国这个结核病负担中等的国家进行的一项全国性研究。
Int J Rheum Dis. 2015 Mar;18(3):323-30. doi: 10.1111/1756-185X.12530. Epub 2015 Jan 3.
5
Tuberculosis Screening and Reactivation Among a National Cohort of Patients with Inflammatory Bowel Disease Treated with Tumor Necrosis Factor Alpha Antagonists.在接受肿瘤坏死因子α拮抗剂治疗的全国性炎症性肠病患者队列中进行的结核病筛查与再激活情况
Inflamm Bowel Dis. 2017 Feb;23(2):254-260. doi: 10.1097/MIB.0000000000001003.
6
Screening for latent tuberculosis in patients with inflammatory bowel disease under antitumor necrosis factor: data from a Portuguese center.炎症性肠病患者在使用肿瘤坏死因子治疗时的潜伏性结核病筛查：来自葡萄牙中心的数据。
Eur J Gastroenterol Hepatol. 2019 Sep;31(9):1099-1102. doi: 10.1097/MEG.0000000000001469.
7
Stringent screening strategy significantly reduces reactivation rates of tuberculosis in patients with inflammatory bowel disease on anti-TNF therapy in tuberculosis endemic region.在结核高发地区，对接受抗 TNF 治疗的炎症性肠病患者采用严格的筛查策略，可显著降低结核再激活率。
Aliment Pharmacol Ther. 2022 Jun;55(11):1431-1440. doi: 10.1111/apt.16839. Epub 2022 Mar 1.
8
Tuberculosis in anti-TNF-α treated patients remains a problem in countries with an intermediate incidence: analysis of 25 patients matched with a control population.抗 TNF-α 治疗患者中的结核病仍然是发病率中等国家的一个问题：25 例患者与对照人群匹配分析。
J Crohns Colitis. 2013 Nov;7(10):e486-92. doi: 10.1016/j.crohns.2013.03.004. Epub 2013 Apr 11.
9
Screening for acquired latent tuberculosis in rheumatoid arthritis patients on tumor necrosis factor inhibition therapy in Southern California.南加州肿瘤坏死因子抑制治疗的类风湿关节炎患者获得性潜伏性结核的筛查。
Clin Rheumatol. 2020 Aug;39(8):2291-2297. doi: 10.1007/s10067-020-04991-y. Epub 2020 Feb 28.
10
Risk of developing tuberculosis under anti-TNF treatment despite latent infection screening.尽管进行了潜伏感染筛查，抗 TNF 治疗仍存在发生结核的风险。
J Crohns Colitis. 2013 Apr;7(3):208-12. doi: 10.1016/j.crohns.2012.05.012. Epub 2012 Jun 5.